Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

15.59
Delayed Data
As of 3:59pm ET
 -0.39 / -2.44%
Today’s Change
9.16
Today|||52-Week Range
17.55
-7.48%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +9.04% increase from the last price of 15.59.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$43.9M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.57%
 
 
 
 
 
 
Growthannually -62.06%
 
 
 
 
 
 

Sales

Growthquarterly 11.51%
 
 
 
 
 
 
Growthannually -29.15%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.